Screener
MBX Biosciences, Inc. MBX Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from MBX Biosciences, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 9:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210593
FAQ
- What is MBX Biosciences, Inc.'s debt-to-equity?
- MBX Biosciences, Inc. (MBX) reported debt-to-equity of 0× in Q1 2026.
- How has MBX Biosciences, Inc.'s debt-to-equity changed year-over-year?
- MBX Biosciences, Inc.'s debt-to-equity increased by 116.7% year-over-year, from 0× to 0×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about MBX Biosciences, Inc.'s debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude